CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...